Modernising Medical Microbiology Logo Modernising Medical Microbiology Retina Logo
RIFlogo
  • Main
  • News
  • Patients and Public
    • Patients and Public
  • Projects
    • CRyPTIC Project
    • NIHR Health Protection Research Unit
    • Antibiotic Reduction & Konservation (ARK) Programme
    • The NIHR Oxford Biomedical Research Centre
    • REHAB: The Environmental Resistome
    • Infections in Oxfordshire Research Database
    • MMM transmission study
    • Health Innovation Challenge Fund (HICF)
  • People
    • Oxford
    • Birmingham
    • Brighton
    • Leeds
    • Collaborators
  • Papers
  • Funding
    • NIHR Health Protection Research Unit
    • The Bill and Melinda Gates Foundation
    • The Medical Research Council UK
    • The NIHR Oxford Biomedical Research Centre
    • The Wellcome Trust
  • Pathogens
  • Art
    • Art
    • ‘Gut Flora’ – Photography and art from the gut
  • Resistance is Futile
  • Contact
Previous Next
  • View Larger Image

Whole Genome Sequencing accurately diagnoses tuberculosis and related diseases

DNA analysis of bacteria taken from sick patients has been shown to be 96% accurate for the diagnosis of tuberculosis (TB) and related diseases, and 99% accurate for predicting resistance to the most common antibiotics used for TB treatment, when compared to existing laboratory tests.

Tuberculosis is more common in the UK than most people realise. On top of that, there are many related organisms in the same family, (known as non-tuberculous mycobacteria) which also cause disease, but which require different drugs to treat them. These related organisms are increasingly being found in sick patients and therefore being able to differentiate between them is becoming more and more important.
Whole Genome Sequencing (WGS) is a relatively new technology which attempts to produce a map of the entire genetic code that makes up an organism. Comparing the DNA code sequence generated from an (initially unknown) organism found in a particular patient to a library of known ‘reference’ sequences, we can identify the exact species based purely on its DNA code. Similarly, we can predict whether the organism is likely to be resistant to certain drugs by looking at specific sections of its genetic code that have previously been shown to be associated with resistance.

Researchers here at MMM and Public Health England tested the new DNA-based technology for a year at the National Mycobacterial Reference Service in Birmingham, (which serves dozens of NHS hospitals across the Midlands and North of England) in order to see how WGS fared compared to existing laboratory methods in a real-life, large-scale environment. We found that although there is still some more work to be done to increase the proportion of samples that yield enough DNA for analysis, when WGS predictions were made, they were very accurate.

—————————————————————————————————————————————————

The original paper can be found at:  http://jcm.asm.org/content/56/2/e01480-17.full

Author: T. Phuong Quan, Statistician and First Author

This work was supported by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the NIHR Health Protection Research Unit (NIHR HPRU) in Healthcare Associated Infections and Antimicrobial Resistance at Oxford University, in partnership with Public Health England (PHE) and by the Department of Health and the Wellcome Trust, through the Health Innovation Challenge (HIC) Fund.

Nicola Fawcett 2018-01-25T13:44:03+00:00

Related Posts

  • Study shows how Electronic Health Records have to be used carefully, to avoid mistakes in analysing infections, and the bacteria causing them
  • July 2019 Newsletter: focus on Influenza
  • Who watches the watchmen?
  • Study looks at why co-amoxiclav-resistant E coli infections are on the rise
  • Can we reduce demand for antibiotic prescriptions? Or might our efforts backfire?

Contact us

Modernising Medical Microbiology
Nuffield Department of Clinical Medicine
University of Oxford, John Radcliffe Hospital
Headington, Oxford OX3 9DU
For media/further information:
crookpm[at]ndm.ox.ac.uk
Research Group Lead:
Professor Derrick Crook
Professor of Microbiology
PA: Betty Coles
Telephone 01865 221226

All original content on this website is copyright to Modernising Medical Microbiology unless otherwise stated.

Modernising Medical Microbiology | Freedom of Information | University Privacy Policy | University Copyright Statement | University Accessibility Statement